A platform for research: civil engineering, architecture and urbanism
Cost-benefit of outcome adjudication in nine randomised stroke trials
Background: Central adjudication of outcomes is common for randomised trials and should control for differential misclassification. However, few studies have estimated the cost of the adjudication process. Methods: We estimated the cost of adjudicating the primary outcome in nine randomised stroke trials (25,436 participants). The costs included adjudicators’ time, direct payments to adjudicators, and co-ordinating centre costs (e.g. uploading cranial scans and general set-up costs). The number of events corrected after adjudication was our measure of benefit. We calculated cost per corrected event for each trial and in total. Results: The primary outcome in all nine trials was either stroke or a composite that included stroke. In total, the adjudication process associated with this primary outcome cost in excess of £100,000 for a third of the trials (3/9). Mean cost per event corrected by adjudication was £2295.10 (SD: £1482.42). Conclusions: Central adjudication is a time-consuming and potentially costly process. These costs need to be considered when designing a trial and should be evaluated alongside the potential benefits adjudication brings to determine whether they outweigh this expense.
Cost-benefit of outcome adjudication in nine randomised stroke trials
Background: Central adjudication of outcomes is common for randomised trials and should control for differential misclassification. However, few studies have estimated the cost of the adjudication process. Methods: We estimated the cost of adjudicating the primary outcome in nine randomised stroke trials (25,436 participants). The costs included adjudicators’ time, direct payments to adjudicators, and co-ordinating centre costs (e.g. uploading cranial scans and general set-up costs). The number of events corrected after adjudication was our measure of benefit. We calculated cost per corrected event for each trial and in total. Results: The primary outcome in all nine trials was either stroke or a composite that included stroke. In total, the adjudication process associated with this primary outcome cost in excess of £100,000 for a third of the trials (3/9). Mean cost per event corrected by adjudication was £2295.10 (SD: £1482.42). Conclusions: Central adjudication is a time-consuming and potentially costly process. These costs need to be considered when designing a trial and should be evaluated alongside the potential benefits adjudication brings to determine whether they outweigh this expense.
Cost-benefit of outcome adjudication in nine randomised stroke trials
Godolphin, P (author) / Bath, P (author) / Algra, A (author) / Berge, E (author) / Chalmers, J (author) / Eliasziw, M (author) / Hankey, G (author) / Hosomi, N (author) / Ranta, A (author) / Weimar, C (author)
2020-07-10
Clinical Trials , 17 (5) pp. 576-580. (2020)
Article (Journal)
Electronic Resource
English
DDC:
690
Wiley | 2020
|British Library Online Contents | 2000
Online Contents | 1996
|IET Digital Library Archive | 2001
British Library Online Contents | 2001
|